author-photo

Kunal Desai

Merck & Co.

13

Papers

179

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement

2021 Cureus
Show All
- Source
- Cite
- Save
Citations (0)
Guillain-Barré Syndrome as a Complication of COVID-19

2021 Cureus
Show All
- Source
- Cite
- Save
Citations (1)
MetAP2 Inhibition Modifies Hemoglobin S (HbS) to Delay Polymerization and Improve Blood Flow in Sickle Cell Disease

2019 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Development of a novel tricyclic class of potent and selective FIXa inhibitors.

2015 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (9)
Development of a novel class of potent and selective FIXa inhibitors

2015 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (12)
Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability

2015 Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (5)
Abstract 568: Biomarkers of Hemostasis and Thrombosis in Hemophilia A and B Patients

2014 Arteriosclerosis, Thrombosis, and Vascular Biology
Show All
- Source
- Cite
- Save
Citations (0)
Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

2014 Journal of Peptide Science
Show All
- Source
- Cite
- Save
Citations (18)
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes

2012 Bioorganic & Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (29)
Effects of peripherally administered neuromedin U on energy and glucose homeostasis.

2011 Endocrinology
Show All
- Source
- Cite
- Save
Citations (40)